Shiyun Cui

1.1k total citations
29 papers, 832 citations indexed

About

Shiyun Cui is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Shiyun Cui has authored 29 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Shiyun Cui's work include MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (7 papers) and RNA modifications and cancer (5 papers). Shiyun Cui is often cited by papers focused on MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (7 papers) and RNA modifications and cancer (5 papers). Shiyun Cui collaborates with scholars based in China and United States. Shiyun Cui's co-authors include Longbang Chen, Rui Wang, Xiang Huang, Jiayuan Huang, Rui Wang, Wei De, Haizhu Song, Yongqian Shu, Yitian Chen and Guichun Huang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cell Death and Disease.

In The Last Decade

Shiyun Cui

28 papers receiving 825 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shiyun Cui China	18	517	404	161	79	77	29	832
Gerson Moura Ferreira Brazil	11	350 0.7×	166 0.4×	181 1.1×	43 0.5×	110 1.4×	26	659
Xiao-Mei Qi United States	16	527 1.0×	114 0.3×	242 1.5×	17 0.2×	81 1.1×	29	809
Weiqing Wu China	14	284 0.5×	127 0.3×	70 0.4×	52 0.7×	35 0.5×	62	545
Alejandra Sandoval Chile	13	474 0.9×	269 0.7×	135 0.8×	140 1.8×	71 0.9×	23	708
Shuangyi Ren China	14	303 0.6×	153 0.4×	176 1.1×	95 1.2×	143 1.9×	62	657
Nupur Mukherjee India	17	415 0.8×	154 0.4×	202 1.3×	45 0.6×	86 1.1×	33	689
Yue He China	14	444 0.9×	299 0.7×	43 0.3×	50 0.6×	66 0.9×	23	712
Xiangyang Lin China	17	466 0.9×	256 0.6×	92 0.6×	53 0.7×	154 2.0×	38	915
Suyanee Thongchot Thailand	17	332 0.6×	201 0.5×	217 1.3×	162 2.1×	130 1.7×	38	720

Countries citing papers authored by Shiyun Cui

Since Specialization

Citations

This map shows the geographic impact of Shiyun Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiyun Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiyun Cui more than expected).

Fields of papers citing papers by Shiyun Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiyun Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiyun Cui. The network helps show where Shiyun Cui may publish in the future.

Co-authorship network of co-authors of Shiyun Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Shiyun Cui. A scholar is included among the top collaborators of Shiyun Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiyun Cui. Shiyun Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cui, Shiyun, Hao Zheng, Qiuyu Wu, et al.. (2025). Plasma proteomic biomarkers predict therapeutic responses in advanced biliary tract cancer patients receiving Camrelizumab plus the GEMOX treatment. npj Precision Oncology. 9(1). 102–102. 2 indexed citations

Chen, Xiaofeng, Xiang Xu, Danping Wang, et al.. (2023). Neoadjuvant sintilimab and chemotherapy in patients with potentially resectable esophageal squamous cell carcinoma (KEEP-G 03): an open-label, single-arm, phase 2 trial. Journal for ImmunoTherapy of Cancer. 11(2). e005830–e005830. 54 indexed citations

Zhu, Chengjun, Jing Xu, Jin‐Yu Sun, et al.. (2022). Circulating Tumor Cells and Breast Cancer Metastasis: From Enumeration to Somatic Mutational Profile. Journal of Clinical Medicine. 11(20). 6067–6067. 5 indexed citations

Meng, Qingqi, Zhiteng Chen, Qing‐Yuan Gao, et al.. (2022). Rosiglitazone Ameliorates Spinal Cord Injury via Inhibiting Mitophagy and Inflammation of Neural Stem Cells. Oxidative Medicine and Cellular Longevity. 2022(1). 5583512–5583512. 7 indexed citations

Wang, Yaomin, et al.. (2021). Mechanisms of primary and acquired resistance to PD-1/PD-L1 blockade and the emerging role of gut microbiome. Clinical & Translational Oncology. 23(11). 2237–2252. 8 indexed citations

Cui, Shiyun, et al.. (2021). MLH1 Exon 12 Gene Deletion Leading to Lynch Syndrome: A Case Report. Oncology Research and Treatment. 44(7-8). 414–421. 3 indexed citations

Wan, Peng, Shiyun Cui, Zhen-Bao Ma, et al.. (2020). Reversal of mcr-1-Mediated Colistin Resistance in Escherichia coli by CRISPR-Cas9 System. Infection and Drug Resistance. Volume 13. 1171–1178. 35 indexed citations

Zhang, Xiufeng, Fangping Li, Shiyun Cui, et al.. (2020). Prevalence and Distribution Characteristics of blaKPC-2 and blaNDM-1 Genes in Klebsiella pneumoniae. Infection and Drug Resistance. Volume 13. 2901–2910. 29 indexed citations

Dang, Yini, Yifeng Zhang, Lingyan Xu, et al.. (2020). PUMA-mediated epithelial cell apoptosis promotes Helicobacter pylori infection-mediated gastritis. Cell Death and Disease. 11(2). 139–139. 17 indexed citations

10.

Sun, Jing, Xiao Zhang, He Huang, et al.. (2020). Rectal metastasis from a previously resected carcinoma of the pancreas: a case report. Translational Cancer Research. 9(4). 3018–3023. 3 indexed citations

11.

Qi, Liang, Ke Zhang, Sumeng Wang, et al.. (2020). Acupuncture for Cancer Pain — An Adjuvant Therapy for Cancer Pain Relief. The American Journal of Chinese Medicine. 48(8). 1769–1786. 17 indexed citations

12.

Wang, Yutong, Ye Fan, Xiao Zhang, et al.. (2020). [Amplification of Extrachromosomal Oncogene and Tumorigenesis and Development].. SHILAP Revista de lepidopterología. 23(12). 1101–1107. 1 indexed citations

13.

Chen, Jing, Xiang Liu, Yichen Xu, et al.. (2019). TFAP2C-Activated MALAT1 Modulates the Chemoresistance of Docetaxel-Resistant Lung Adenocarcinoma Cells. Molecular Therapy — Nucleic Acids. 14. 567–582. 53 indexed citations

14.

Huang, Xiang, Shiyun Cui, & Yongqian Shu. (2015). Cisplatin selectively downregulated the frequency and immunoinhibitory function of myeloid-derived suppressor cells in a murine B16 melanoma model. Immunologic Research. 64(1). 160–170. 51 indexed citations

15.

Cui, Shiyun, Yanping Gao, Kai Zhang, et al.. (2015). The Emerging Role of Inhibitor of Growth 4 as a Tumor Suppressor in Multiple Human Cancers. Cellular Physiology and Biochemistry. 36(2). 409–422. 19 indexed citations

16.

Chen, Dongqin, Banzhou Pan, Jiayuan Huang, et al.. (2014). HDAC 1/4-mediated silencing of microRNA-200b promotes chemoresistance in human lung adenocarcinoma cells. Oncotarget. 5(10). 3333–3349. 46 indexed citations

17.

Cui, Shiyun, Rui Wang, & Longbang Chen. (2014). MicroRNA‐145: a potent tumour suppressor that regulates multiple cellular pathways. Journal of Cellular and Molecular Medicine. 18(10). 1913–1926. 128 indexed citations

18.

Huang, Jiayuan, Shiyun Cui, Yitian Chen, et al.. (2013). MicroRNA-650 Was a Prognostic Factor in Human Lung Adenocarcinoma and Confers the Docetaxel Chemoresistance of Lung Adenocarcinoma Cells via Regulating Bcl-2/Bax Expression. PLoS ONE. 8(8). e72615–e72615. 64 indexed citations

19.

Cui, Shiyun, Jiayuan Huang, Yitian Chen, et al.. (2013). The role of Aurora A in hypoxia-inducible factor 1α-promoting malignant phenotypes of hepatocelluar carcinoma. Cell Cycle. 12(17). 2849–2866. 28 indexed citations

20.

Chen, Yuxin, Shiyun Cui, Zhipeng Xu, et al.. (2012). Losartan improves erectile dysfunction in diabetic patients: a clinical trial. International Journal of Impotence Research. 24(6). 217–220. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact